Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/13267
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2023-03-24T18:34:27Z-
dc.date.available2023-03-24T18:34:27Z-
dc.date.issued2002-10-
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/13267-
dc.publisherINCApt_BR
dc.subjectEnergia Nuclearpt_BR
dc.subjectNuclear Energypt_BR
dc.subjectEnergía Nuclearpt_BR
dc.subjectRadioterapia (Especialidade)pt_BR
dc.subjectRadiation Oncologypt_BR
dc.subjectOncología por Radiaciónpt_BR
dc.titleNo início de outubro a Direção Geral do INCA recebeu a notícia oficialpt_BR
dc.title.alternativeInforme INCA 134pt_BR
dc.TypePeriodicalpt_BR
Appears in Collections:Informe INCA 134

Files in This Item:
File Description SizeFormat 
Informe-INCA-2002-134-3-No-início-de.pdf82.82 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.